Anaptysbio

ANABNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.676 B

$56.61 +3.36%

Close of 7 Aug 2026

Revenue

$234.6M

#2249 by revenue

Earnings

-$13.2M

Loss-making

Shares outstanding

29,100,902

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#130ZymeworksZYME$1.72B
#131Obsidian TherapeuticsOBX$1.70B
#132AnaptysbioANAB$1.68B
#133Maravai LifesciencesMRVI$1.61B
#134Tyra BiosciencesTYRA$1.58B

Where these numbers come from

Share counts and financials for Anaptysbio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.